AstraZeneca (AZN)

Add to Watchlists
Create an Alert
31.58 -0.66  -2.05% NYSE Sep 4, 14:54 Delayed 2m USD

AstraZeneca Enterprise Value:

88.03B for Sept. 3, 2015

View 4,000+ financial data types

Browse...
View Full Chart

AstraZeneca Enterprise Value Chart

Export Data
Save Image

AstraZeneca Historical Enterprise Value Data

View and export this data going back to 1994. Start your Free Trial
Export Data Date Range:
Data for this Date Range  
Sept. 3, 2015 88.03B
Sept. 2, 2015 86.62B
Sept. 1, 2015 84.11B
Aug. 31, 2015 85.61B
Aug. 28, 2015 86.59B
Aug. 27, 2015 86.44B
Aug. 26, 2015 85.23B
Aug. 25, 2015 83.08B
Aug. 24, 2015 83.99B
Aug. 21, 2015 86.49B
Aug. 20, 2015 88.82B
Aug. 19, 2015 90.84B
Aug. 18, 2015 91.77B
Aug. 17, 2015 91.50B
Aug. 14, 2015 91.12B
Aug. 13, 2015 91.04B
Aug. 12, 2015 90.91B
Aug. 11, 2015 92.61B
Aug. 10, 2015 92.53B
Aug. 7, 2015 91.70B
Aug. 6, 2015 93.09B
Aug. 5, 2015 93.85B
Aug. 4, 2015 93.34B
Aug. 3, 2015 92.33B
July 31, 2015 91.95B
   
July 30, 2015 91.82B
July 29, 2015 89.98B
July 28, 2015 89.47B
July 27, 2015 89.22B
July 24, 2015 89.65B
July 23, 2015 90.65B
July 22, 2015 91.50B
July 21, 2015 92.03B
July 20, 2015 92.29B
July 17, 2015 91.88B
July 16, 2015 91.95B
July 15, 2015 92.34B
July 14, 2015 92.28B
July 13, 2015 91.45B
July 10, 2015 90.52B
July 9, 2015 88.12B
July 8, 2015 87.84B
July 7, 2015 89.46B
July 6, 2015 88.84B
July 2, 2015 89.21B
July 1, 2015 88.23B
June 30, 2015 87.06B
June 29, 2015 88.23B
June 26, 2015 90.75B
June 25, 2015 90.15B

There is no data for the selected date range.

An error occurred. Please try again by refreshing your browser or contact us with details of your problem.

About Enterprise Value

Click "Learn More" below to see how YCharts calculates Enterprise Value.

Enterprise Value (EV) is a valuation metric alternative to traditional market capitalization that reflects the market value of an entire business. Like market cap, EV is a measure of what the market believes a company is worth. Enterprise value captures the cost of an entire business, including debt and equity. It is a sum of claims of all preferred shareholders, debt holders, security holders, common equity holders, and minority shareholders - unlike market cap, which only captures the total value of common equity securities.

EV is considered the theoretical purchase ("takeover") price of a business because a purchaser would take on the company's debt, while pocketing the company's cash and gaining a right to all of the company's future earnings.
Learn More

Advertisement

AZN Enterprise Value Benchmarks

Companies
GlaxoSmithKline 109.07B
Pfizer 201.86B
Novartis 247.78B

AZN Enterprise Value Range, Past 5 Years

Minimum 50.61B Jun 05 2012
Maximum 107.46B May 01 2014
Average 73.09B

AZN Enterprise Value Excel Add-In Codes

  • Metric Code: enterprise_value
  • Latest data point: =YCP("AZN", "enterprise_value")
  • Last 5 data points: =YCS("AZN", "enterprise_value", -4)

To find the codes for any of our financial metrics, see our Complete Reference of Metric Codes.

Access our powerful Excel Add-in with a YCharts Professional Membership. Learn More.

Advertisement

You've hit the 10 page limit on YCharts.

Experience the power of YCharts.
Start your Free 7-Day Trial.

Start My Free Trial No credit card required.

Already a subscriber? Sign in.

{{root.upsell.info.feature_headline}}.

{{root.upsell.info.feature_description}}
Start your free 7-Day Trial.

{{root.upsell.info.button_text}} No credit card required.

Already a subscriber? Sign in.